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ndrew N. Redington, MD, FRCP
oronto, Canada
OBJECTIVES We conducted a randomized controlled trial of the effects of remote ischemic preconditioning
(RIPC) in children undergoing repair of congenital heart defects.
BACKGROUND Remote ischemic preconditioning reduces injury caused by ischemia-reperfusion in distant
organs. Cardiopulmonary bypass (CPB) is associated with multi-system injury. We hypoth-
esized that RIPC would modulate injury induced by CPB.
METHODS Children undergoing repair of congenital heart defects were randomized to RIPC or control
treatment. Remote ischemic preconditioning was induced by four 5-min cycles of lower limb
ischemia and reperfusion using a blood pressure cuff. Measurements of lung mechanics,
cytokines, and troponin I were made pre- and postoperatively.
RESULTS Thirty-seven patients were studied. There were 20 control patients and 17 patients in the
RIPC group. The mean age and weight of the RIPC and control patients were not different
(0.9  0.9 years vs. 2.2  3.4 years, p  0.4; and 6.9  2.9 kg vs. 11.5  10 kg, p  0.06).
Bypass and cross-clamp times were not different (80 24 min vs. 88 25 min, p 0.3; and
55  13 min vs. 59  13 min, p  0.4). Levels of troponin I postoperatively were greater in
the control patients compared with the RIPC group (p 0.04), indicating greater myocardial
injury in control patients. Postoperative inotropic requirement was greater in the control
patients compared with RIPC patients at both 3 and 6 h (7.9  4.7 vs. 10.9  3.2, p  0.04;
and 7.3 4.9 vs. 10.8 3.9, p 0.03, respectively). The RIPC group had significantly lower
airway resistance at 6 h postoperatively (p  0.009).
CONCLUSIONS This study demonstrates the myocardial protective effects of RIPC using a simple noninvasive
technique of four 5-min cycles of lower limb ischemia and reperfusion. These novel data
support the need for a larger study of RIPC in patients undergoing cardiac surgery. (J Am
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.01.066Coll Cardiol 2006;47:2277–82) © 2006 by the American College of Cardiology Foundation
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dschemic preconditioning is an innate protective mechanism
hat markedly reduces ischemia-reperfusion (IR) injury in
ost human tissues. Although local ischemic precondition-
ng, induced by short-lived non-fatal ischemia in the target
issue, has been shown to be of benefit in patients under-
oing coronary angioplasty and surgical revascularization in
ome studies (1,2), other studies (3,4) have been less
onclusive. Furthermore, the clinical applicability of local
reconditioning is limited by the need to induce ischemia in
he target organ, a process that itself may induce dysfunction
nd that is clearly inappropriate for global myocardial
rotection.
A more clinically relevant stimulus is afforded by remote
schemic preconditioning (RIPC). The concept of RIPC
as first described by Przyklenk et al. (5). Transient
schemia of the left circumflex territory was shown to reduce
From the Divisions of Cardiology and Cardiovascular Surgery, Critical Care
edicine and Anaesthesia, Hospital for Sick Children, Toronto, Canada. This work
as supported by the Heart and Stroke Foundation of Canada and the Canadian
nstitute of Health Research.v
Manuscript received November 8, 2005; revised manuscript received January 10,
006, accepted January 16, 2006.he effects of subsequent potentially lethal ischemia in the
eft anterior descending artery territory in dogs. Further
tudies in rodent models demonstrated that ischemia of the
idney and intestine may induce myocardial protection
6,7). Although providing proof of principle, none of these
tudies has particular relevance to protection against IR
njury in the clinical setting. We have recently demonstrated
8) that skeletal muscle ischemia is a potent preconditioning
timulus in humans and larger animals. Four 5-min episodes
f limb ischemia induced by inflation of a blood-pressure
uff prevented ischemic endothelial dysfunction in the
orearm in normal volunteers and reduced infarct size in a
orcine model of myocardial infarction. The same stimulus,
hen applied to the recipient, protects the donor heart
gainst IR injury in a cardiac transplant model (9) and has
een shown to modify expression of proinflammatory genes
n circulating human neutrophils (10). Furthermore, in a
orcine model of cardiopulmonary bypass (CPB), RIPC
fforded myocardial and pulmonary protection (11,12). This
as evidenced by lower levels of troponin I and shorter
uration of lactic acidosis, in addition to lower pulmonary
ascular resistance, and significantly less change in pulmo-
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Remote Preconditioning in Children June 6, 2006:2277–82ary vascular resistance and lower peak inspiratory pressure
fter CPB in comparison with control patients. Open-heart
urgery in children results in a predictable IR injury with a
ell-documented systemic inflammatory reaction. We
herefore hypothesized that RIPC would provide protection
gainst myocardial IR injury and systemic inflammation in
hildren undergoing CPB for repair of congenital heart
efects.
ETHODS
he study protocol was approved by the institutional re-
earch ethics board. Informed consent was obtained before
nrollment in the study. Children undergoing surgical repair
f congenital heart defects were randomized to RIPC or a
ontrol group. Staff involved in the clinical care and mem-
ers of the study group obtaining functional data were
linded to randomization for the period of data acquisition
nd analysis. Group allocation was not revealed until the
nal statistical analysis. All subjects were studied under
eneral anesthesia at the time of surgical repair. Children
ndergoing all types of open-heart surgery were included,
xcept for those with isolated atrial septal defect and those
ith a bidirectional cavopulmonary shunt undergoing Fon-
an completion. These patient groups were excluded because
ypass times are relatively short and duration of stay in the
ntensive care unit is often 24 h. Patients with chromo-
omal defects, airway and parenchymal lung disease, immu-
odeficiency, or blood disorders were excluded. Anesthesia
as induced with sevoflurane and maintained with a com-
ination of intravenous fentanyl and inhaled isoflurane in air
nd oxygen. Muscle relaxants were used in all patients.
ollowing insertion of central venous and arterial catheters
nd a 5-min period of stabilization, the following baseline
easurements were made before sternotomy.
ung function. Airflow and airway opening pressure were
easured with a fixed-orifice differential flow sensor
CO2SMO Plus, Novametrix Medical Systems Inc., Wall-
ngford, Connecticut) inserted between the endotracheal
ube and the ventilator Y-piece. Recordings of dynamic
ompliance and airway resistance were stored in the memory
f the CO2SMO Plus.
lood analysis. Arterial blood was sampled from the arte-
ial catheter for measurements of the cytokines interleukin
IL)-6, IL-8, and IL-10, tumor necrosis factor (TNF)-
lpha, and levels of troponin I. Samples were collected and
Abbreviations and Acronyms
A-a O2  alveolar-arterial oxygen
CPB  cardiopulmonary bypass
ECG  electrocardiographic/electrocardiogram
IL  interleukin
IR  ischemia-reperfusion
RIPC  remote ischemic preconditioning
TNF  tumor necrosis factormmediately centrifuged, and the resulting plasma and terum was frozen at 70°C for later analysis. Analysis of
evels of cytokines and troponin I was made using commer-
ially available kits (Immulite, Diagnostic Products Corpo-
ation, California, and Bayer Immuno 1, Bayer AG, Ger-
any) respectively.
otal body water. A gross assessment of the systemic
nflammatory response and the associated capillary leak was
ade by measuring changes in total body water. Two pairs
f electrocardiographic (ECG) electrodes were applied to
he arm and leg. Body resistivity was measured using a
odystat 1500 (Bodystat, Isle of Man, United Kingdom).
he principle underlying the non-invasive technique of
io-impedance analysis is the difference in resistivity of fluid
ithin the body compared with lean tissue. The method has
een validated and has been used following cardiopulmo-
ary bypass in children (13).
emote preconditioning protocol. Remote ischemic pre-
onditioning was induced by four 5-min cycles of lower
imb ischemia and 5-min reperfusion using a blood-pressure
uff inflated to a pressure 15 mm Hg greater than the
ystolic arterial pressure measured via the arterial line.
ontrol patients underwent sham placement of the blood
ressure cuff around the leg without inflation. There was a
- to 10-min interval between completion of the RIPC
rotocol and initiation of bypass.
urgical repair. All children underwent surgical repair
sing standard cardiopulmonary bypass techniques with
lood cardioplegia. The duration of cardiopulmonary bypass
nd aortic cross-clamp time was recorded. None of the
atients studied received perioperative steroids. Modified
ltrafiltration was carried out in all children.
ostoperative assessment. All measurements were re-
eated at 3, 6, 12, and 24 h after bypass, with additional
easurements of mixed venous saturation and urine output.
lveolar-arterial oxygen (A-a O2 gradient) and oxygenation
ndex were calculated in the usual way. Inotropic support at
ach time point was quantified by calculating the inotropic
core as described previously (14,15).
tatistical analysis. Data are presented as mean  SD,
xcept in figures where error bars represent SEM. Data were
ompared by two-way ANOVA (Model 1, fixed effects) or
npaired t test, with the analysis of variance assessed by an
test. All tests were two-tailed. A p value 0.05 was
onsidered significant. Data were analyzed using GraphPad
rism (version 4.0, GraphPad Software Inc., San Diego,
alifornia).
ESULTS
atients. Thirty-seven patients were studied. No local
dverse effects related to the RIPC stimulus were observed.
here were 20 control patients and 17 in the RIPC group.
atients with ventricular septal (8 control and 7 RIPC) and
trioventricular septal defects (1 control and 3 RIPC),
etralogy of Fallot (10 control and 5 RIPC), aortic regurgi-
ation undergoing valve repair (1 RIPC), and transposition
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June 6, 2006:2277–82 Remote Preconditioning in Childrenf the great arteries (1 in each group) were studied. The
ean age and weight of the RIPC and control groups were
ot significantly different (0.9  0.9 years vs. 2.2  3.4
ears, p  0.4; and 6.9  2.9 kg vs. 11.5  10.1 kg; p 
.06). Mean bypass and cross-clamp times were not signif-
cantly different (80  24 min vs. 88  25 min, p  0.3 and
5 13 min vs. 59 13 min; p 0.4). No patients were left
ith hemodynamically significant residual lesions. Length
f stay in intensive care for RIPC and control groups was
ot significantly different (54.2  40.7 h vs. 39.5  25.7 h,
espectively; p  0.3). Duration of ventilation for the RIPC
nd control groups was not significantly different (30.4 
3.8 h vs. 25.0  36.6 h, respectively; p  0.6).
yocardial function and injury. Levels of troponin I
ostoperatively were significantly greater in the control
atients as compared with the RIPC group (p  0.04),
ndicating greater myocardial injury in controls (Fig. 1).
ecause previous studies have shown greater release of
roponin I in patients undergoing resection of muscle
undles associated with right ventricular outflow tract ob-
truction in tetralogy of Fallot (16), these data were reana-
yzed excluding the data from this group of patients, and the
ifference between controls and RIPC patients remained
ignificantly different (p  0.04).
There was no difference in values of mixed venous
aturation or urine output between the two groups through-
ut the postoperative period (Table 1). There was, however,
significantly greater inotropic requirement in the control
roup compared with the RIPC group at both 3 and 6 h
7.9  4.7 g/kg/min vs. 10.9  3.2 g/kg/min, p  0.04;
nd 7.3  4.9 g/kg/min vs. 10.8  3.9 g/kg/min, p 
.03, respectively) (Fig. 2).
ung function. Airway resistance and dynamic compliance
t baseline and postoperative time intervals are shown in
able 1. There were no significant differences in the
aseline or 3-h postoperative values for airway resistance;
owever, the RIPC group had significantly lower airway
esistance at 6 h postoperatively (p  0.009) (Fig. 3). Thereigure 1. Pre- and postoperative levels of troponin I in remote ischemic
reconditioning (RIPC) and control groups. Ta
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Remote Preconditioning in Children June 6, 2006:2277–82as no significant difference in postoperative values of
ynamic compliance between the two groups. A-a O2
radient and oxygenation index were not significantly dif-
erent between the two groups (Table 1).
ystemic inflammatory response. Mean levels of the cy-
okines IL-6, IL-8, IL-10, and TNF-alpha at 3 and 6 h
ere not significantly different for the two groups of
atients (Table 1). There was increased variance of IL-10
nd a reduction in the variance of levels of TNF-alpha in the
IPC group. These were significantly different for IL-10 at
h (p 0.03) and TNF-alpha at 6 h (p 0.0001) (Fig. 4).
There were no differences in values of bioimpedence for
he two groups (Table 1).
ISCUSSION
his study is the first demonstration of the clinical effec-
iveness of RIPC. Our simple protocol of transient limb
schemia provided protection against myocardial and pul-
onary IR injury and also modulated the systemic inflam-
atory response in children undergoing open-heart surgery.
linical studies of local preconditioning. Clinical studies
f local ischemic preconditioning in patients undergoing
oronary angioplasty have shown conflicting data. A study
y Bolli et al. (3) reported the beneficial protective effect of
reconditioning in humans. In their study of patients
ndergoing coronary angioplasty, balloon inflations after the
igure 2. Postoperative inotrope scores in remote ischemic precondition-
ng (RIPC) and control groups.p
igure 3. Airway resistance (RAW) in remote ischemic preconditioning
RIPC) and control groups.nitial “preconditioning” inflation were associated with less
iastolic and systolic dysfunction, less ST-segment elevation
n intracoronary ECG, and less myocardial lactate produc-
ion. Furthermore, in those patients given adenosine before
ngioplasty, there was amelioration of the effects of the first
alloon inflation in comparison with control patients. The
uthors presented these data to support the existence of
reconditioning in humans and that preconditioning could
e induced by both direct myocardial ischemia and adeno-
ine. In contrast, a randomized double-blind trial of the
ffects of the adenosine triphosphate-sensitive potassium
hannel opener pinacidil, the potassium channel blocker
libenclamide, and placebo during coronary angioplasty
howed no evidence of ischemic preconditioning in humans
4). Using a similar angioplasty protocol to that of Bolli et
l. (3), we found no significant differences in ECG ST-
egment changes, ventricular function assessed by radionu-
lide detector, or symptoms of angina. The situation in
umans is clearly more complicated than the more con-
rolled environment of animal studies. The effects of co-
orbidity such as diabetes, hypertension and subsequent
herapy, and the potential for a “preconditioning” effect of
ccult myocardial ischemia before angioplasty all conspire to
ake interpretation of the results of these studies difficult.
Reduction in degree of myocardial necrosis due to prior
ocal ischemic preconditioning has been demonstrated in
atients undergoing coronary artery bypass grafting. Yellon
t al. (2) reported significant reduction in troponin T release
n those patients randomized to receive local ischemic
reconditioning by two 3-min periods of aortic cross-
lamping and rapid pacing, each followed by 2 min of
eperfusion. As the authors pointed out, however, there is
eluctance to subject patients with an already tenuous
irculation to this type of stress, which has been well
escribed to induce ventricular dysfunction. This is also
elevant to the applicability of local ischemic precondition-
ng of the heart in children before repair of congenital
efects.
One of the obvious advantages of our technique of remote
reconditioning is its non-invasive nature and ease of
pplication. Furthermore, in contrast to local ischemic
igure 4. Levels of interleukin (IL)-10 at 3 h and tumor necrosis factor
TNF)-alpha at 6 h postoperatively in remote ischemic preconditioning
RIPC) and control groups.reconditioning, the effects of transient skeletal muscle
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2281JACC Vol. 47, No. 11, 2006 Cheung et al.
June 6, 2006:2277–82 Remote Preconditioning in Childrenschemia are relatively benign, there being no myocardial
ysfunction, risk of arrhythmia, low cardiac output, or
econdary organ injury. Additionally, the “non-local” effect
f RIPC may afford more widespread protection against
R injury and the CPB-induced systemic inflammatory
esponse.
emote preconditioning and the systemic inflammatory
esponse. Ischemia-reperfusion injury and CPB during
ardiac surgery are associated with a predictable systemic
nflammatory response, myocardial dysfunction, and pulmo-
ary endothelial dysfunction. These events may contribute
o postoperative morbidity and mortality in any patient after
eart surgery, but are particularly prominent in infants
ndergoing repair of congenital lesions. First, CPB itself,
ecause of contact of blood with the extracorporeal circuit
nd direct trauma to its cellular constituents, drives a
eutrophil-mediated inflammatory response. Second, IR
njury of the cardiopulmonary bed during aortic cross-
lamping leads to a secondary inflammatory response and
oncomitant alterations in gene expression affecting both
he inflammatory process and pathways controlling pro-
rammed cell death or apoptosis. Our previous study of
uman neutrophils following RIPC, induced by four 5-min
ycles of upper-limb ischemia, demonstrated modulation of
enes coding for key proteins involved in cytokine synthesis,
eukocyte chemotaxis, adhesion and migration, exocytosis,
nnate immunity-signaling pathways, and apoptosis (10).
his led to the hypothesis that organ injury associated with
ardiopulmonary bypass might be reduced.
In this study, we did not observe any significant difference
n the mean levels of IL-6, IL-8, IL-10, or TNF-alpha.
here were, however, even within this relatively small group
f patients, significant differences in variance of levels of
L-10 and TNF-alpha. The deleterious effects of high levels
f TNF-alpha; induced by CPB are well described, includ-
ng myocardial depression (17), capillary leak, and pulmo-
ary dysfunction (18). Furthermore, in vivo dog experi-
ents have demonstrated time-dependent myocardial
ysfunction following intravenous infusion of TNF-alpha
19,20). Importantly, the overall response is modulated by
he anti-inflammatory cytokine IL-10 (21) through inhibi-
ion of expression of TNF-alpha. The current data are
onsistent with an acute modification of inflammatory
athways with RIPC. It should be pointed out, however,
hat in our previous study, whereas the anti-inflammatory
ene responses were significantly down-regulated at 15 min
fter the RIPC stimulus, the responses were markedly
mplified at 24 h. These data are consistent with the
ell-described phenomenon of a second window (starting
pproximately 24 to 48 h after the stimulus) of protection
fforded by ischemic preconditioning. Although this is
peculative, one might therefore anticipate that further
eneficial modification of the inflammatory response to
ardiopulmonary bypass may occur if the RIPC stimulus
ere applied one day before surgery. Further studies are
learly required to explore this, however. tung function. Endothelial dysfunction and impairment
f mechanical properties of the lung following CPB are well
escribed (22–25). These effects are mediated by neutrophil
ctivation leading to the release of proteases and oxygen
adical species. Although neutrophil function was not as-
essed in this study, it has been shown previously (26) that
IPC reduced neutrophil activation and endothelial dys-
unction in a human forearm model of IR-induced injury.
urthermore, in a human study of aortic cross-clamping to
recondition the heart before valve replacement, it was
oted that the increase in leukocyte numbers, thromboxane
2, and malondialdehyde levels in pulmonary venous blood
rom the lung was attenuated by preconditioning of the
eart (27). There was also less lung injury histologically and
lower lung leukocyte count compared with control patients
ithout myocardial preconditioning. These data may rep-
esent inadvertent remote preconditioning of the lungs and
re consistent with our observations of differences in airway
esistance postoperatively in this study and our findings of
ower pulmonary vascular resistance and improved lung
echanics in a porcine model of CPB (11).
yocardial injury and ventricular function. Our previous
tudy (8) showed that RIPC induced by a similar protocol of
imb ischemia reduced myocardial IR injury in a porcine
odel of myocardial infarction induced by balloon coronary
cclusion. Congenital heart surgery is associated with a
redictable global myocardial IR insult as a result of aortic
ross-clamping. We have previously shown (28) a measur-
ble degree of left ventricular dysfunction even after repair
f “simple” congenital defects. Furthermore, many studies
ave demonstrated global myocardial damage using surro-
ate markers such as troponin I and T. In the current study,
e used levels of troponin I as our primary measure of
yocardial injury. Control patients had significantly higher
evels of troponin I release in the postoperative period. The
ariation in troponin I levels at each time point for RIPC
atients was also reduced in comparison with control
atients. Despite significantly greater myocardial injury in
he control group, there were no differences in indices of
ardiac output and systemic perfusion such as mixed venous
aturation and urine output. Because intensive care man-
gement is aimed at maintaining adequate cardiac output
uided by these indices, the lack of a difference is not
urprising. Consequently, the higher inotrope requirement
t 3 and 6 h can be interpreted as reflecting a greater degree
f myocardial dysfunction in the control group.
tudy limitations. In this preliminary study of the effects
f RIPC in a clinical setting, we purposely chose children
ndergoing surgical repair of a diverse range of congenital
eart defects with a wide age range. Despite randomization
f these patients, the mean age and weight of the control
atients were greater; however, this did not reach statistical
ignificance. A larger multicenter study of these effects will
llow the possibly variable effects of RIPC in discrete
ubgroups of patients to be studied. This is important, as
here is a wide inter-individual variation in, for example,
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Remote Preconditioning in Children June 6, 2006:2277–82nflammatory cytokine responses, as illustrated by the cur-
ent data. Because patients with both increased and de-
reased pulmonary blood flow were included in this study,
his may have confounded our measurements of lung me-
hanics. Furthermore, although there are reports of the
reconditioning properties of inhalational anesthetics and
any other diverse stimuli, patients in this study were
andomized to RIPC or control groups and all underwent
he same anesthetic, CPB, and intensive care management
rotocols to minimize bias.
It is impossible to examine the optimal timing and
dministration of the ischemic preconditioning stimulus
rom the current study. We chose to replicate the stimulus
hown to be effective in experimental models and our
rotocol shown to modify human neutrophil gene re-
ponses. The risk-benefit ratio of this therapy is so striking
hat further studies should be directed toward optimizing
he stimulus, as well as the possible additional benefits from
he second window of protection using RIPC.
ummary. We have demonstrated the myocardial protec-
ive effects of remote ischemic preconditioning using a
imple noninvasive technique of four 5-min cycles of lower
imb ischemia and reperfusion. These novel data support the
eed for a larger study of RIPC in patients undergoing
ardiac surgery and the potential additional benefit afforded
y second-window preconditioning.
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